These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35802036)

  • 21. Influence of age at seizure onset on the acquisition of neurodevelopmental skills in an SCN8A cohort.
    Encinas AC; Moore IKM; Watkins JC; Hammer MF
    Epilepsia; 2019 Aug; 60(8):1711-1720. PubMed ID: 31335965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The phenotypic spectrum of SCN8A encephalopathy.
    Larsen J; Carvill GL; Gardella E; Kluger G; Schmiedel G; Barisic N; Depienne C; Brilstra E; Mang Y; Nielsen JE; Kirkpatrick M; Goudie D; Goldman R; Jähn JA; Jepsen B; Gill D; Döcker M; Biskup S; McMahon JM; Koeleman B; Harris M; Braun K; de Kovel CG; Marini C; Specchio N; Djémié T; Weckhuysen S; Tommerup N; Troncoso M; Troncoso L; Bevot A; Wolff M; Hjalgrim H; Guerrini R; Scheffer IE; Mefford HC; Møller RS;
    Neurology; 2015 Feb; 84(5):480-9. PubMed ID: 25568300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What have we learned from the real-world efficacy of FFA in DS and LGS? A post-marketing study in clinical practice.
    Valls Carbó A; Beltrán Á; Sánchez-Miranda Román I; Cabal B; Gómez-Porro P; Aledo-Serrano Á; López Sobrino G; Ayuga F; Gómez Eguilaz M; Gil-Nagel A
    Epilepsy Behav; 2024 Feb; 151():109620. PubMed ID: 38194770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial.
    Knupp KG; Scheffer IE; Ceulemans B; Sullivan JE; Nickels KC; Lagae L; Guerrini R; Zuberi SM; Nabbout R; Riney K; Shore S; Agarwal A; Lock M; Farfel GM; Galer BS; Gammaitoni AR; Davis R; Gil-Nagel A
    JAMA Neurol; 2022 Jun; 79(6):554-564. PubMed ID: 35499850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical features and genetic analysis of five children with epilepsies due to variants of SCN8A gene].
    Zhang X; Qiu S; Yang L; Li Y; Xu N; Yu X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Feb; 41(2):174-180. PubMed ID: 38311555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variant-specific changes in persistent or resurgent sodium current in SCN8A-related epilepsy patient-derived neurons.
    Tidball AM; Lopez-Santiago LF; Yuan Y; Glenn TW; Margolis JL; Clayton Walker J; Kilbane EG; Miller CA; Martina Bebin E; Scott Perry M; Isom LL; Parent JM
    Brain; 2020 Oct; 143(10):3025-3040. PubMed ID: 32968789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multi-disciplinary clinic for SCN8A-related epilepsy.
    Schreiber JM; Tochen L; Brown M; Evans S; Ball LJ; Bumbut A; Thewamit R; Whitehead MT; Black C; Boutzoukas E; Fanto E; Suslovic W; Berl M; Hammer M; Gaillard WD
    Epilepsy Res; 2020 Jan; 159():106261. PubMed ID: 31887642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical study of 19 patients with SCN8A-related epilepsy: Two modes of onset regarding EEG and seizures.
    Denis J; Villeneuve N; Cacciagli P; Mignon-Ravix C; Lacoste C; Lefranc J; Napuri S; Damaj L; Villega F; Pedespan JM; Moutton S; Mignot C; Doummar D; Lion-François L; Gataullina S; Dulac O; Martin M; Gueden S; Lesca G; Julia S; Cances C; Journel H; Altuzarra C; Ben Zeev B; Afenjar A; Barth M; Villard L; Milh M
    Epilepsia; 2019 May; 60(5):845-856. PubMed ID: 31026061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin-Positive Interneurons Contribute to Seizures in
    Wengert ER; Miralles RM; Wedgwood KCA; Wagley PK; Strohm SM; Panchal PS; Idrissi AM; Wenker IC; Thompson JA; Gaykema RP; Patel MK
    J Neurosci; 2021 Nov; 41(44):9257-9273. PubMed ID: 34544834
    [No Abstract]   [Full Text] [Related]  

  • 30. SCN8A encephalopathy: Research progress and prospects.
    Meisler MH; Helman G; Hammer MF; Fureman BE; Gaillard WD; Goldin AL; Hirose S; Ishii A; Kroner BL; Lossin C; Mefford HC; Parent JM; Patel M; Schreiber J; Stewart R; Whittemore V; Wilcox K; Wagnon JL; Pearl PL; Vanderver A; Scheffer IE
    Epilepsia; 2016 Jul; 57(7):1027-35. PubMed ID: 27270488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome.
    Lenk GM; Jafar-Nejad P; Hill SF; Huffman LD; Smolen CE; Wagnon JL; Petit H; Yu W; Ziobro J; Bhatia K; Parent J; Giger RJ; Rigo F; Meisler MH
    Ann Neurol; 2020 Mar; 87(3):339-346. PubMed ID: 31943325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of fenfluramine in patients with Dravet syndrome: A systematic review and meta-analysis.
    Sharawat IK; Panda PK; Kasinathan A; Panda P; Dawman L; Joshi K
    Seizure; 2021 Feb; 85():119-126. PubMed ID: 33461030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SCN8A heterozygous variants are associated with anoxic-epileptic seizures.
    Ranza E; Z'Graggen W; Lidgren M; Beghetti M; Guipponi M; Antonarakis SE; Absoud M; Goyal S; Pal DK; Korff CM
    Am J Med Genet A; 2020 May; 182(5):1209-1216. PubMed ID: 32040247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astrocyte reactivity in a mouse model of SCN8A epileptic encephalopathy.
    Thompson JA; Miralles RM; Wengert ER; Wagley PK; Yu W; Wenker IC; Patel MK
    Epilepsia Open; 2022 Jun; 7(2):280-292. PubMed ID: 34826216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic and genetic spectrum in Chinese children with SCN8A-related disorders.
    Hu C; Luo T; Wang Y
    Seizure; 2022 Feb; 95():38-49. PubMed ID: 34979445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
    Gil-Nagel A; Falip M; Sánchez-Carpintero R; Abad-Sazatornil MR; Poveda JL; Aibar JÁ; Cardenal-Muñoz E; Aras LM; Sánchez R; Sancho-López A; Trillo-Mata JL; Torrejón M; Gil A
    Epilepsy Behav; 2022 Jul; 132():108711. PubMed ID: 35588562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electroclinical features of epileptic encephalopathy caused by SCN8A mutation.
    Takahashi S; Yamamoto S; Okayama A; Araki A; Saitsu H; Matsumoto N; Azuma H
    Pediatr Int; 2015 Aug; 57(4):758-62. PubMed ID: 25951352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SCN8A Epilepsy, Developmental Encephalopathy, and Related Disorders.
    Talwar D; Hammer MF
    Pediatr Neurol; 2021 Sep; 122():76-83. PubMed ID: 34353676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy.
    Wagnon JL; Korn MJ; Parent R; Tarpey TA; Jones JM; Hammer MF; Murphy GG; Parent JM; Meisler MH
    Hum Mol Genet; 2015 Jan; 24(2):506-15. PubMed ID: 25227913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early onset epileptic encephalopathy caused by de novo SCN8A mutations.
    Ohba C; Kato M; Takahashi S; Lerman-Sagie T; Lev D; Terashima H; Kubota M; Kawawaki H; Matsufuji M; Kojima Y; Tateno A; Goldberg-Stern H; Straussberg R; Marom D; Leshinsky-Silver E; Nakashima M; Nishiyama K; Tsurusaki Y; Miyake N; Tanaka F; Matsumoto N; Saitsu H
    Epilepsia; 2014 Jul; 55(7):994-1000. PubMed ID: 24888894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.